The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS)—for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL ...
May 10, 2019
2
244
An international research consortium led by UC San Francisco scientists has shown significant differences between the gut bacteria profiles of multiple sclerosis (MS) patients and healthy individuals, as well as between MS ...
Sep 15, 2022
0
91
An international team of researchers led by Karolinska Institutet in Sweden reports that cells in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) ...
Feb 4, 2022
0
28
Although multiple sclerosis (MS) is known to run in certain families, attempts to find genes linked to the disease have been elusive. Now for the first time researchers are reporting a gene mutation that can be connected ...
Jun 1, 2016
0
247
A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases.
Jan 24, 2023
0
1017
In the relentless battle against multiple sclerosis (MS), U of A researchers recently discovered an entirely new cellular mechanism—an underlying defect in brain cells—that may to be blame for the disease, and a potential ...
Mar 23, 2017
0
69
Seasonal flare-ups in patients with multiple sclerosis are caused by plummeting levels of melatonin in the spring and summer, according to research published September 10 in Cell. The study reveals that relapses in patients ...
Sep 10, 2015
0
218
Researchers have made another important step in the progress towards being able to block the development of multiple sclerosis (MS) and other autoimmune diseases.
Oct 29, 2015
0
211
A new study led by UC San Francisco scientists shows that a bacterium commonly found in the human gut is overrepresented in patients with a rare, often disabling autoimmune disease known as neuromyelitis optica, or NMO. The ...
Aug 5, 2016
0
112
A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common ...
Aug 5, 2020
0
77
